2024-12-25 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**1. Performance Comparison & Divergence:**

Colgate-Palmolive (CL) is a consumer goods company that manufactures and sells oral hygiene, personal care, and household products.

The cumulative return for CL is 41.53%, significantly lagging behind the S&P 500 (VOO) with a cumulative return of 120.69%.  The difference is -79.2%, placing it at the 1.1 percentile of its historical range against the S&P 500 based on the provided data. This indicates substantial underperformance compared to the benchmark index.  The provided CAGR data shows inconsistent performance across different periods, ranging from -12% to 32%.


**2. Recent Price Movement:**

* **Closing Price:** $92.39
* **5-Day Moving Average:** $92.40
* **20-Day Moving Average:** $94.04
* **60-Day Moving Average:** $95.58

The current price is below all three moving averages, suggesting a short-term downtrend.

**3. Technical Indicators & Expected Return:**

* **RSI (36.47):** Indicates the stock is approaching oversold territory.
* **PPO (-0.14):** Shows a bearish momentum.
* **20-Day Relative Divergence (-1.6):** Suggests a recent period of underperformance relative to the market.
* **Expected Return (0.0%):**  The model projects no significant outperformance against the S&P 500 over the long term (2+ years) based on current data.  The provided 0.0% is likely a placeholder and requires more robust forecasting models.  Given the historical underperformance, achieving S&P 500 parity in the long term is far from guaranteed.


**4. Recent Earnings Analysis:**

The provided earnings data shows relatively stable revenue around $5 billion, with minor fluctuations.  EPS shows a slight upward trend, with a minor dip in Q1 2024.  There's no information on whether these results beat or missed expectations.  More detailed information is needed for a complete assessment.  Note the duplicate entry for October 25, 2024. This inconsistency requires clarification.


**5. Financial Information Analysis:**

* **Revenue:** Revenue has been relatively stable in the recent past but shows slight decline in the last quarter compared to Q1 and Q2 2024.
* **Profit Margin:**  Profit margins are high and have generally been trending slightly downwards.
* **Equity & ROE:**  Equity and ROE show high volatility, with extremely high and negative values in different quarters. This suggests significant changes in accounting or unusual financial activities that require further investigation.  The extreme values (-7866.67% ROE) warrant deep scrutiny to understand the underlying causes.


**6. News and Recent Issues:**

No recent news or market outlook is provided.  Analyst opinions and performance highlights are also missing.  This crucial information gap prevents a comprehensive assessment of the current market sentiment surrounding CL.


**7. Overall Analysis:**

Colgate-Palmolive (CL) exhibits significant underperformance relative to the S&P 500, both in terms of cumulative return and recent momentum.  Technical indicators suggest the stock is nearing oversold conditions, but this should be considered in the context of the long-term underperformance.  Earnings data shows relatively stable revenue and slightly increasing EPS, but lacks context regarding market expectations.  The highly volatile equity and ROE figures require further investigation.  The absence of recent news and analyst opinions limits the ability to offer a comprehensive outlook.  The projected 0.0% long-term expected return relative to the S&P 500 should be treated with caution, as it likely stems from a basic model and lacks crucial information regarding future expectations. More detailed financial statements, market analysis, and news information are necessary for a complete and reliable evaluation.


**8. Recommendations:**

Given the significant underperformance against the S&P 500, the volatile financial metrics, and the lack of current market information, a deeper dive into the company's financials, strategic direction, and competitive landscape is strongly recommended before making any investment decisions.  The high volatility of ROE and the lack of context regarding Q4 2023 and Q1 2024's financial reports raises significant red flags regarding financial soundness.  Further investigation is necessary to resolve these inconsistencies and determine the long-term investment potential of CL.
